Update on the ELIANA trial (VIDEO)

Article

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

Related Videos
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Angela Nash, PhD, APRN, CPNP-PC, PMHS | Image credit: UTHealth Houston
Allison Scott, DNP, CPNP-PC, IBCLC
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC
Juanita Mora, MD
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Related Content
Image credit: © Olga Sidel'nikova - stock.adobe.com

Dupilumab safe, effective for up to 1 year for atopic dermatitis in infants, preschool children

May 3rd 2024
Article

According to new study data presented at the 2024 Pediatric Academic Societies Meeting, dupilumab (dupixent; Sanofi and Regeneron) demonstrated positive safety and efficacy results for up to 1 year in infants and preschool-age children with atopic dermatitis.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Higher BMI, obesity probability not associated with early peanut introduction | Image Credit: © Stepan Popov - © Stepan Popov - stock.adobe.com.

Higher BMI, obesity probability not associated with early peanut introduction

May 3rd 2024
Article

A poster session evaluated early evidence from the randomized controlled iREACH trial.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Nirsevimab reduced RSV hospitalizations in infants by 82%, new data shows | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Nirsevimab reduced RSV hospitalizations in infants by 82%, new data show

May 2nd 2024
Article

The new data, published in The Lancet, showed that nirsevimab substantially reduced RSV hospitalizations.

How healthy do parents think their children's diets are? | Image Credit: © Seventyfour- © Seventyfour - stock.adobe.com.

Parent perspectives: How are parents providing healthy diets for their children?

May 1st 2024
Article

A recent nationally representative survey revealed what types of meals parents believe are healthy for their children, and how much food is the healthy amount.

© 2024 MJH Life Sciences

All rights reserved.